Cargando…
Alterations in Tau Metabolism in ALS and ALS-FTSD
There is increasing acceptance that amyotrophic lateral sclerosis (ALS), classically considered a neurodegenerative disease affecting almost exclusively motor neurons, is syndromic with both clinical and biological heterogeneity. This is most evident in its association with a broad range of neuropsy...
Autores principales: | Strong, Michael J., Donison, Neil S., Volkening, Kathryn |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7719764/ https://www.ncbi.nlm.nih.gov/pubmed/33329356 http://dx.doi.org/10.3389/fneur.2020.598907 |
Ejemplares similares
-
Phosphorylation of Threonine 175 Tau in the Induction of Tau Pathology in Amyotrophic Lateral Sclerosis—Frontotemporal Spectrum Disorder (ALS-FTSD). A Review
por: Moszczynski, Alexander J., et al.
Publicado: (2018) -
Frontal and Cerebellar Atrophy Supports FTSD-ALS Clinical Continuum
por: Pizzarotti, Beatrice, et al.
Publicado: (2020) -
Upregulation of LRRK2 following traumatic brain injury does not directly phosphorylate Thr(175) tau
por: Donison, Neil, et al.
Publicado: (2023) -
(18)
F-FDG Brain PET/MRI in Amyotrophic Lateral Sclerosis– Frontotemporal Spectrum Disorder (ALS-FTSD)
por: Mashriqi, Faizullah, et al.
Publicado: (2023) -
Synergistic toxicity in an in vivo model of neurodegeneration through the co-expression of human TDP-43(M337V) and tau(T175D) protein
por: Moszczynski, Alexander J., et al.
Publicado: (2019)